Our capabilities for studying behaviour and the behavioural effects of drugs have improved steadily over the past decades as a result of methodological innovations and the introduction of novel techniques in Behavioural Pharmacology. Advances in behavioural methods and neurochemistry have enabled the examination of neurochemical mechanisms that mediate the behavioural effects of many different types of psychoactive drugs, as well as the examination of disturbances in brain chemistry that might be related to psychiatric disorders. The development of genetically modified research animals has provided an important avenue of research into the behavioural role of targeted neurochemical pathways, whereas impressive advances in neuroimaging technologies have made it feasible to obtain in-vivo information on regional occupancy of targeted receptor populations with PET or patterns of neural activation with functional MRI. Without doubt, steady streams of innovation will continue to redefine our scientific horizons and identify exciting new opportunities in behavioural pharmacological research. Therefore, we are happy to announce that the topic of the 2017 Special Issue of Behavioural Pharmacology will be novel techniques for the study of drugs and behavior. This is expected to be a wide-ranging Special Issue that includes but is not restricted to advances in molecular biology, genetics or genomics, and neuroimaging, which can be used to advantage in studies of drugs and behaviour. Examples of recent innovations that already impact research in Behavioural Pharmacology are the emergence of CRISPRCas9 for gene editing and the use of DREADDS or optogenetics to control neuronal activity. This Special Issue is intended to provide examples of innovative research across a broad spectrum of topic areas pertaining to the study of drugs and behaviour, including studies in both laboratory animals and human subjects.
We now invite behavioural pharmacologists employing novel techniques or innovative methodology in their research to submit reports of original, unpublished empirical studies for inclusion in the Special Issue. We also welcome review papers, but as the Special Issue may include a number of invited reviews these should be discussed with the editors at an early stage to avoid duplication. Also, please ask one of the editors if you are uncertain whether a report of your research would be suitable for inclusion.
All papers should be submitted online at http://www.editorialmanager.com/bpharm. Contributors are urged to submit as early as possible, and should in any case aim to do so before the end of March 2017. Later submissions might be accepted, but the later your submission is received, the higher the likelihood that it may miss the publication deadline. We guarantee, however, that any submission that meets quality standards but is accepted too late for inclusion in the Special Issue will be published as soon as possible thereafter.
Paul Willner (Editor)
Jack Bergman (Associate Editor)
Louk Vanderschuren (Associate Editor)
Bart Ellenbroek (Reviews Editor)